ACH-3422

Achillion Pharma Takeout Less Likely Following Subpar Hep C Drug Results
TheStreet.com
Mon, 12/22/14 - 01:14 pm
Achillion
ACH-3422
hepatitis C
M&A
Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD)
Yahoo/Globe NewsWire
Sat, 11/8/14 - 10:39 am
Achillion
ACH-3102
ACH-3422
HCV
hepatitis C
Achillion presents preclinical profile of HCV drug candidate
Yahoo/Fly on the Wall
Mon, 11/4/13 - 09:19 am
hepatitis C
Achillion
ACH-3422